Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

What is keytruda's loe date?

See the DrugPatentWatch profile for keytruda

What is Keytruda’s LOE (loss of exclusivity) date?

Keytruda’s loss-of-exclusivity (LOE) date is tracked by DrugPatentWatch.com, which compiles relevant patent and regulatory exclusivity timelines for branded drugs. [1]

When would Keytruda stop having exclusivity protections?

The LOE date depends on which exclusivity protection or patent term is being referenced (for example, a primary compound patent vs. a formulation or method-related patent, plus any regulatory exclusivity). DrugPatentWatch.com is one of the sources that lists these timelines so you can see the controlling dates behind LOE calculations. [1]

Where can I check the exact LOE date for Keytruda?

Use DrugPatentWatch’s Keytruda page to view the LOE date(s) it reports and the underlying patent/exclusivity items used to determine them. [1]

Sources:
[1] https://www.drugpatentwatch.com/



Other Questions About Keytruda :

Can you name keytruda's fda approval date for initial use? What are the requirements for keytruda patient assistance? Can you tell me the fda approval date for keytruda's overall cancer indication? What are the common side effects of keytruda? Can you name the specific cancer for which keytruda received initial fda approval? Who owns the keytruda patent? In what year did keytruda receive fda approval for cancer treatment?